Effect of Plantago major on Ulcerative colitis
Phase 3
Recruiting
- Conditions
- lcerative colitis.Ulcerative colitis
- Registration Number
- IRCT20181018041375N1
- Lead Sponsor
- Shahed University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Having the clinical symptoms of Ulcerative colitis that confirmed by endoscopy and biopsy
Age 15-70 years
Exclusion Criteria
Pregnancy or breast feeding
Massive bleeding or need to hospitalization or emergent surgery
Fulminant colitis, Peritonitis, Toxic megacolon, Colorectal cancer, Stricture, Obstruction
Using of Antibiotics, Herbal drugs,OCPs, NSAIDs or Hormonal therapy(in last 2 weeks)
Concurrent important and severe disease:liver, kidney or heart disease, cancer or Celiac disease
Cigarette or opioids addiction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of clinical symptoms of Ulcerative colitis (remission, mild, moderate, sever). Timepoint: 0, 4, 8 weeks. Method of measurement: Lichtiger Clinical Index.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: 4, 8 weeks. Method of measurement: Drug side effects questionnaire.;General Mizaj. Timepoint: 0, 8 weeks. Method of measurement: Mojahedi Mizaj questionnaire.